Synlett 2016; 27(07): 1116-1120
DOI: 10.1055/s-0035-1561219
letter
© Georg Thieme Verlag Stuttgart · New York

FeCl3-Catalyzed Three-Component One-Pot Synthesis of Novel 4-[(Benzo[d]thiazol-2-ylamino)(phenyl)methyl]-3-hydroxy-9H-xanthen-9-ones

Vandana Cherkadu
a   Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India   Email: priyabs_chem@yahoo.com
b   R&D Centre, CJEX Biochem 7&8, 2nd Cross, Muniswamappa Layout, Hosur Road, Bommanahalli Bangalore 560 068, India
,
Praveen Kumar Kalavagunta
c   Crop Protection Chemicals Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India
,
Mallesha Ningegowda
b   R&D Centre, CJEX Biochem 7&8, 2nd Cross, Muniswamappa Layout, Hosur Road, Bommanahalli Bangalore 560 068, India
,
Nanjunda Swamy Shivananju
d   Department of Biotechnology, Sri Jayachamarajendra College of Engineering, Mysore 570006, India
,
Mahendra Madegowda
e   Department of Studies in Physics, University of Mysore, Manasagangotri, Mysore 570 006, India
,
Babu Shubha Priya*
a   Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India   Email: priyabs_chem@yahoo.com
› Author Affiliations
Further Information

Publication History

Received: 04 November 2015

Accepted after revision: 06 December 2015

Publication Date:
11 January 2016 (online)


Abstract

A novel three-component one-pot synthesis method using FeCl3 in DMF as a suitable catalyst and solvent system has been developed for the synthesis of 4-[(benzo[d]thiazol-2-ylamino)(phenyl)methyl]-3-hydroxy-9H-xanthen-9-ones. The method so developed illustrates the successful utilization of 3-hydroxyxanthones in a multicomponent reaction using a variety of aldehydes and 2-aminobenzothiazoles for the first time.

Supporting Information

 
  • References and Notes

  • 2 Xu L.-W, Xia C.-G, Li L. J. Org. Chem. 2004; 69: 8482
  • 3 Teh SS, Ee GC. L, Mah SH, Lim YM, Ahmad Z. Molecules 2013; 18: 1985
  • 4 Thorson MK, Majtan T, Kraus JP, Barrios AM. Angew. Chem. Int. Ed. 2013; 52: 4641
  • 5 Leao M, Gomes S, Pedraza-Chaverri J, Machado N, Sousa E, Pinto M, Inga A, Pereira C, Saraiva L. J. Nat. Prod. 2013; 76: 774
    • 6a Al-Massarani SM, El Gamal AA, Al-Musayeib NM, Mothana RA, Basudan OA, Al-Rehaily AJ, Farag M, Assaf MH, El Tahir KH, Maes L. Molecules 2013; 18: 10599
    • 6b Gokaraju GR, Gokaraju RR, Gokaraju VK. R. R, Golakoti T, Bhupathiraju K, Alluri VK. R. US 201345183, 2013
  • 7 Ren Y, Matthew S, Lantvit DD, Ninh TN, Chai H, Fuchs JR, Soejarto DD, Carcache De Blanco EJ, Swanson SM, Kinghorn AD. J. Nat. Prod. 2011; 74: 1117
  • 8 Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, Kim YS, Lee BW, Park KH. Phytochemistry 2011; 72: 2148
  • 9 Verbanac D, Jain SC, Jain N, Chand M, Paljetak HČ, Matijašić M, Perić M, Stepanić V, Saso L. Bioorg. Med. Chem. 2012; 20: 3180
  • 11 Tanaka N, Kashiwada Y, Kim SY, Sekiya M, Ikeshiro Y, Takaishi Y. Phytochemistry 2009; 70: 1456
  • 12 Lin C.-N, Won S.-J, Lieu H.-S, Liou S.-S. US 005741813A, 1998
  • 14 Kasibhatla S, Cai SX, Tseng B, Jessen KA, English NM, Maliartchouk S, Jiang S, Sirisoma NS, Zhang H.-Z, Kuemmerle J. US 20050004026 A1, 2005
  • 15 Zhou ZT, Wang JW. Chin. J. New Drugs 2007; 16: 79
  • 16 Sun H, Chen F, Wang X, Liu Z, Yang Q, Zhang X, Zhu J, Qiang L, Guo Q, You Q. Eur. J. Med. Chem. 2012; 51: 110
  • 18 Rampa A, Piazzi L, Belluti F, Gobbi S, Bisi A, Bartolini M, Andrisano V, Cavrini V, Cavalli A, Recanatini M, Valenti P. J. Med. Chem. 2001; 44: 3810
  • 19 Zhang X, Li X, Sun H, Jiang Z, Tao L, Gao Y, Guo Q, You Q. Org. Biomol. Chem. 2012; 10: 3288
    • 20a Delmas F, Di Giorgio C, Robin M, Azas N, Gasquet M, Detang C, Costa M, Timon-David P, Galy J.-P. Antimicrob. Agents Chemother. 2002; 46: 2588
    • 20b Goguen J, Ning P, Kyungae L. WO 2009145829, 2009
    • 20c Saeed S, Rashid N, Jones PG, Ali M, Hussain R. Eur. J. Med. Chem. 2010; 45: 1323
    • 20d Shaban AA, Butler IS, Gilson DF. R, Bertrand JJ. C, Mouhri ZS, Mostafa MM, Mostafa SI. Inorg. Chim. Acta B 2014; 423: 242
    • 20e Valderrama JA, Ríos D, Muccioli GG, Calderon PB, Brito I, Benites J. Tetrahedron Lett. 2015; 56: 5103
  • 21 Dvorak HF, Zeng H (Beth Israel Deaconess Medical Center) WO 200867061, 2008
    • 22a DiMauro TM, Attawia M, Toselli R, Lilienfeld S. US 200731341, 2007
    • 22b Wang Y. US 200657065, 2006
  • 23 Van der Valk JB. F, Vijverberg HP. M. Eur. J. Pharmacol. 1993; 232: 131
  • 25 Navarrete-Vazquez G, Ramírez-Martínez M, Estrada-Soto S, Nava-Zuazo C, Paoli P, Camici G, Escalante-García J, Medina-Franco JL, López-Vallejo F, Ortiz-Andrade R. Eur. J. Med. Chem. 2012; 53: 346
  • 29 General Procedure: 3-Hydroxyxanthone (1 mmol), benzaldehyde (1 mmol), and 2-aminobenzothiazole (1 mmol) were added to a 10 mL round-bottom flask. To this DMF (0.3 mL) was added, followed by 0.2 equiv of FeCl3. The resulting mixture was heated at 120 °C until the reaction was completed as indicated by TLC (ca. 2 h). The reaction mixture is then cooled to r.t., quenched with H2O, extracted with EtOAc, the combined extracts dried, filtered, the solvent removed, and the residue purified by column chromatography. 4-[(Benzo[d]thiazol-2-ylamino)(phenyl)methyl]-3-hydroxy-9H-xanthen-9-one (4e) Compound 4e was obtained in 91% yield as an off-white solid; mp 180 °C. 1H NMR (400 MHz, DMSO-d 6): δ = 11.73–11.12 (br s, 1 H), 8.85 (d, 1 H, J = 7.8 Hz), 8.11 (dd, 1 H, J 1 = 7.8 Hz, J 2 = 1.2 Hz), 8.03 (d, 1 H, J = 8.8 Hz), 7.81 (dt, 1 H, J 1 = 8.8 Hz, J 2 = 1.2 Hz), 7.67 (d, 1 H, J = 7.8 Hz), 7.60 (d, 1 H, J = 8.8 Hz), 7.47 (d, 2 H, J = 7.8 Hz), 7.42 (t, 1 H, J = 7.8 Hz), 7.37–7.29 (m, 3 H), 7.22–7.13 (m, 3 H), 7.06 (d, 1 H, J = 8.8 Hz), 7.01 (t, 1 H, J = 6.8 Hz). 13C NMR (100 MHz, DMSO-d 6): δ = 175.4, 166.2, 161.5, 155.8, 152.6, 142.2, 135.1, 131.1, 128.6, 127.3, 127.0, 126.6, 126.0, 125.9, 124.6, 121.5, 121.4, 121.3, 118.8, 118.6, 115.7, 114.8, 114.1, 52.1. IR: νmax = 3270, 3062, 1639, 1617, 1604, 1573, 1538, 1466, 1439, 1310, 1221, 1148, 1058, 1033, 754, 698 cm–1. LC–MS: m/z = 449 [M – H]. HRMS: m/z calcd for C27H19O3N2S: 451.1111; found: 451.1085.